China Pharma Holdings, Inc. (CPHI) stock
CPHINYSEPharmaceutical PreparationsFiscal year ends December 31
$0.54−0.01 (-1.43%)
Close on Nov 11, 2026Market cap $23.37MP/E –Yield –
China Pharma operating margin
Operating margin is operating income as a percentage of revenue.
China Pharma's operating margin for the twelve months ending Jun 30, 2026 was -111.8%. For fiscal 2025 it was -78.2%, against -101.3% the year before. The highest annual figure on record is 33.2% in fiscal 2010.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -78.2% | +23.2 |
| FY2024 | Dec 31, 2024 | -101.3% | −62.1 |
| FY2023 | Dec 31, 2023 | -39.2% | +4.5 |
| FY2022 | Dec 31, 2022 | -43.8% | −14.1 |
| FY2021 | Dec 31, 2021 | -29.7% | −5.9 |
| FY2020 | Dec 31, 2020 | -23.7% | +163.1 |
| FY2019 | Dec 31, 2019 | -186.8% | −102.1 |
| FY2018 | Dec 31, 2018 | -84.7% | +56.7 |
| FY2017 | Dec 31, 2017 | -141.4% | −89.0 |
| FY2016 | Dec 31, 2016 | -52.4% | +17.9 |
| FY2015 | Dec 31, 2015 | -70.3% | +104.8 |
| FY2014 | Dec 31, 2014 | -175.1% | −118.4 |
| FY2013 | Dec 31, 2013 | -56.7% | −67.5 |
| FY2012 | Dec 31, 2012 | 10.8% | −16.3 |
| FY2011 | Dec 31, 2011 | 27.1% | −6.0 |
| FY2010 | Dec 31, 2010 | 33.2% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -151.0% | −87.4 |
| Q1 FY2026 | Mar 31, 2026 | -113.6% | −46.8 |
| Q4 FY2025 | Dec 31, 2025 | -97.9% | +7.6 |
| Q3 FY2025 | Sep 30, 2025 | -83.1% | +15.6 |
| Q2 FY2025 | Jun 30, 2025 | -63.6% | +86.9 |
| Q1 FY2025 | Mar 31, 2025 | -66.8% | +0.1 |
| Q4 FY2024 | Dec 31, 2024 | -105.5% | −50.4 |
| Q3 FY2024 | Sep 30, 2024 | -98.6% | −59.1 |
| Q2 FY2024 | Jun 30, 2024 | -150.4% | −108.9 |
| Q1 FY2024 | Mar 31, 2024 | -66.9% | −46.6 |
| Q4 FY2023 | Dec 31, 2023 | -55.1% | −15.1 |
| Q3 FY2023 | Sep 30, 2023 | -39.6% | −4.5 |
| Q2 FY2023 | Jun 30, 2023 | -41.6% | +6.8 |
| Q1 FY2023 | Mar 31, 2023 | -20.3% | +36.6 |
| Q4 FY2022 | Dec 31, 2022 | -40.0% | −17.6 |
| Q3 FY2022 | Sep 30, 2022 | -35.0% | +3.5 |
| Q2 FY2022 | Jun 30, 2022 | -48.3% | −17.2 |
| Q1 FY2022 | Mar 31, 2022 | -56.8% | −27.3 |
| Q4 FY2021 | Dec 31, 2021 | -22.5% | +15.1 |
| Q3 FY2021 | Sep 30, 2021 | -38.5% | +1.1 |
| Q2 FY2021 | Jun 30, 2021 | -31.2% | −33.2 |
| Q1 FY2021 | Mar 31, 2021 | -29.5% | +4.4 |
| Q4 FY2020 | Dec 31, 2020 | -37.6% | +575.0 |
| Q3 FY2020 | Sep 30, 2020 | -39.7% | −12.5 |
| Q2 FY2020 | Jun 30, 2020 | 2.0% | +31.3 |
| Q1 FY2020 | Mar 31, 2020 | -34.0% | −22.6 |
| Q4 FY2019 | Dec 31, 2019 | -612.6% | −381.0 |
| Q3 FY2019 | Sep 30, 2019 | -27.1% | +56.9 |
| Q2 FY2019 | Jun 30, 2019 | -29.3% | −2.1 |
| Q1 FY2019 | Mar 31, 2019 | -11.4% | −7.5 |
| Q4 FY2018 | Dec 31, 2018 | -231.6% | +124.2 |
| Q3 FY2018 | Sep 30, 2018 | -84.0% | −19.0 |
| Q2 FY2018 | Jun 30, 2018 | -27.2% | +45.8 |
| Q1 FY2018 | Mar 31, 2018 | -3.9% | +20.5 |
| Q4 FY2017 | Dec 31, 2017 | -355.8% | −297.6 |
| Q3 FY2017 | Sep 30, 2017 | -65.0% | −15.5 |
| Q2 FY2017 | Jun 30, 2017 | -73.1% | – |
| Q1 FY2017 | Mar 31, 2017 | -24.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -58.2% | – |
| Q3 FY2016 | Sep 30, 2016 | -49.5% | – |
See a number that looks wrong?